id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-1111-1709,FDA,FDA-2016-N-1111,"Attachment 6 Linked Profile of Quentin Davies re: Supplemental Comment from Eckert Seamans  Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T13:57:54Z,,0,0,090000648254a525
FDA-2016-N-1111-1706,FDA,FDA-2016-N-1111,"Attachment 3 Article from ASAN ""Tell the FDA: Ban Electric Shock Torture of People with Disabilities"" re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T13:47:59Z,,0,0,090000648254a522
FDA-2016-N-1111-1707,FDA,FDA-2016-N-1111,"Attachment 4 Article from Change.org ""USA Today: Time to ban skin shocks to disabled"" re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T13:50:42Z,,0,0,090000648254a523
FDA-2016-N-1111-1716,FDA,FDA-2016-N-1111,"Attachment 13 Instructions for Use Amplatzer PFO Occluder re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:42:57Z,,0,0,090000648254a53d
FDA-2016-N-1111-1705,FDA,FDA-2016-N-1111,"Attachment 2 Letter from Hogan Lovells to FDA CDRH January 16, 2013 re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:01:56Z,,0,0,090000648254a521
FDA-2016-N-1111-1712,FDA,FDA-2016-N-1111,"Attachment 9 Police Report Canton Police Department re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:11:59Z,,0,0,090000648254a539
FDA-2016-N-1111-1710,FDA,FDA-2016-N-1111,"Attachment 7 Letter from Hogan Lovells to FDA CDRH February 1, 2013 re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:00:21Z,,0,0,090000648254a526
FDA-2016-N-1111-1708,FDA,FDA-2016-N-1111,"Attachment 5 Article from Silence Breaking Sound ""Tell the FDA: Stop the Shock!"" re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T13:53:24Z,,0,0,090000648254a524
FDA-2016-N-1111-1713,FDA,FDA-2016-N-1111,"Attachment 10 Letter from Judge Rotenberg Center December 21, 2016 re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:18:08Z,,0,0,090000648254a53a
FDA-2016-N-1111-1715,FDA,FDA-2016-N-1111,"Attachment 12 Letter from FDA CDRH to St. Jude Medical, Inc. re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:37:10Z,,0,0,090000648254a53c
FDA-2016-N-1111-1719,FDA,FDA-2016-N-1111,"Attachment 16 Letter from FDA CDRH to Micro Interventional Devices, Inc. re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T15:08:33Z,,0,0,090000648254a540
FDA-2016-N-1111-1714,FDA,FDA-2016-N-1111,"Attachment 11 JRC Policy Procedures and Rules for GED Applications and Approvals re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:20:55Z,,0,0,090000648254a53b
FDA-2016-N-1111-1703,FDA,FDA-2016-N-1111,"Supplemental Comment from Eckert Seamans re: Judge Rotenberg Educational Center, Inc.",Other,Supplemental Comment,2017-04-11T04:00:00Z,2017,4,2017-04-11T04:00:00Z,,2017-04-11T12:42:09Z,,0,0,0900006482549ba0
FDA-2016-N-1111-1711,FDA,FDA-2016-N-1111,"Attachment 8 Product Description of Antabuse Disulfran Tablet re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:12:15Z,,0,0,090000648254a538
FDA-2016-N-1111-1717,FDA,FDA-2016-N-1111,"Attachment 14 Letter from FDA CDRH to Edwards Lifesciences, LLC August 12, 2016 re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T14:50:34Z,,0,0,090000648254a53e
FDA-2016-N-1111-1718,FDA,FDA-2016-N-1111,"Attachment 15 Edwards Intuity Elite Valve System re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T15:11:28Z,,0,0,090000648254a53f
FDA-2016-N-1111-1704,FDA,FDA-2016-N-1111,"Attachment 1 Linked Profile of James Eason re: Supplemental Comment from Eckert Seamans  Judge Rotenberg Educational Center, Inc.",Supporting & Related Material,Background Material,2017-04-11T04:00:00Z,2017,4,,,2017-04-11T13:42:05Z,,0,0,090000648254a520